Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

Haemato Reset Filter
All Issuers BankM AG GBC AG
15.12.2023 09:31AM
Study issued by GBC AG

HAEMATO AG (von GBC AG): suspended

suspended
Delisting of the HAEMATO share to take place from February 2023; price potential not yet exhausted; GBC-rating and GBC-price target suspended   HAEMATO has announced the termination of the inclusion of the shares in the open market of 30 November 2023. The shares are to be delisted after expiry of the notice period, at the latest by the end  [ … ]
Read More
Original Research
DE000A289VV1 A289VV
Haemato
13.12.2023 10:01AM
Study issued by First Berlin Equity Research GmbH

Haemato AG (von First Berlin Equity Research GmbH): Not Rated

Not Rated
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin hat seine bisherige Buy-Empfehlung und sein bisheriges Kursziel von EUR 34,00 wegen des bevorstehenden Delistings zurückgenommen. Zusammenfassung: Haemato wird die Notierung ihrer Aktien im Open Market der Frank [ … ]
Read More
Original Research
DE000A289VV1 A289VV
Haemato
10.12.2021 12:31PM
Study issued by GBC AG

HAEMATO AG (von GBC AG): Management Interview

Management Interview
In operational terms, HAEMATO AG is heading for a record year following the acquisition of M1 Aesthetics GmbH. In addition, the expansion of their private label business is increasingly coming into focus. In this regard, the company plans to expand its portfolio with a botulinum toxin product under its own brand. GBC analyst Cosmin Filker spoke wi [ … ]
Read More
Original Research
DE000A289VV1 A289VV
Haemato

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2024          
boersengefluester.de · #BGFL · © 2024
The news manufactory
Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Quick Links

About us
Testimonials
Referenzen
Media Kid
Privacy
Terms of use
Imprint

Network

Baha
EQS News
Finanznachrichten
Server 24

Partner

BankM
Cometis
Cross Alliance
Fino Digital
GBC
Monetga

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL